[96a5a0]: / output / allTrials / identified / NCT00470301_identified.json

Download this file

682 lines (682 with data), 29.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
{
"info": {
"nct_id": "NCT00470301",
"official_title": "A Phase I-II Study of R115777 (Tipifarnib, Zarnestra®) Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Stage IIB-IIIC Breast Cancer",
"inclusion_criteria": "* Histologically or cytologically confirmed adenocarcinoma of the breast; clinical stage IIB, IIIA, IIIB, or IIIC disease\n* At least 1 week since prior tamoxifen or other selective estrogen receptor modulator for prevention or for other indications (e.g., osteoporosis or prior ductal carcinoma in situ)\n* HER-2/neu-negative by immunohistochemistry or fluorescence in situ hybridization (FISH)\n* Hormone receptor status:\n\n * Estrogen and/or progesterone receptor-positive* [Note: *Patients enrolled on the phase I portion of the trial may have estrogen and progesterone receptor-negative disease]\n* Normal organ function including:\n* WBC >= 3,000/mm^3\n* Absolute neutrophil count >= 1,500/mm^3\n* Platelet count >= 100,000/mm^3\n* Bilirubin normal\n* AST and ALT =< 2.5 times upper limit of normal\n* LVEF normal by echocardiogram or nuclear scan\n* Creatinine normal OR Creatinine clearance >= 60 mL/min\n* FEV1 >= 1 L* and DLCO >= 50%* [Note: *Only if baseline CT scan of chest shows parenchymal lung disease OR there is a history of chronic obstructive or other pulmonary disease]\n* No prior chemotherapy, radiotherapy, or definitive therapeutic surgery (e.g., mastectomy, lumpectomy, or axillary dissection) for this cancer but prior sentinel lymph node biopsy for this malignancy allowed\n* No prior adjuvant chemotherapy for a previous breast malignancy\n* No concurrent combination antiretroviral therapy for HIV-positive patients\n* No other concurrent investigational agents\n* No other concurrent anticancer agents or therapies\n* ECOG performance status 0-1\n* Fertile patients must use effective contraception\n\nExclusion criteria:\n\n* No other invasive malignancy within the past 5 years except curatively treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix\n* No history of allergic reactions attributed to compounds of similar chemical or biological composition to tipifarnib or other study drugs (e.g., imidazoles or quinolones)\n* No other uncontrolled illness including, but not limited to, any of the following: ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric illness/social situations that would preclude study compliance\n* Not pregnant or nursing\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically confirmed adenocarcinoma of the breast; clinical stage IIB, IIIA, IIIB, or IIIC disease",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed adenocarcinoma of the breast",
"criterion": "adenocarcinoma of the breast",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "clinical stage IIB, IIIA, IIIB, or IIIC disease",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"IIB",
"IIIA",
"IIIB",
"IIIC"
]
}
]
}
]
},
{
"line": "* At least 1 week since prior tamoxifen or other selective estrogen receptor modulator for prevention or for other indications (e.g., osteoporosis or prior ductal carcinoma in situ)",
"criterions": [
{
"exact_snippets": "At least 1 week since prior tamoxifen or other selective estrogen receptor modulator",
"criterion": "time since prior selective estrogen receptor modulator",
"requirements": [
{
"requirement_type": "time since last use",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "week"
}
}
]
}
]
},
{
"line": "* HER-2/neu-negative by immunohistochemistry or fluorescence in situ hybridization (FISH)",
"criterions": [
{
"exact_snippets": "HER-2/neu-negative by immunohistochemistry or fluorescence in situ hybridization (FISH)",
"criterion": "HER-2/neu status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
},
{
"requirement_type": "testing method",
"expected_value": [
"immunohistochemistry",
"fluorescence in situ hybridization (FISH)"
]
}
]
}
]
},
{
"line": "* Hormone receptor status:",
"criterions": [
{
"exact_snippets": "Hormone receptor status",
"criterion": "hormone receptor status",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
},
{
"line": "* Estrogen and/or progesterone receptor-positive* [Note: *Patients enrolled on the phase I portion of the trial may have estrogen and progesterone receptor-negative disease]",
"criterions": [
{
"exact_snippets": "Estrogen and/or progesterone receptor-positive",
"criterion": "hormone receptor status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"estrogen receptor-positive",
"progesterone receptor-positive"
]
}
]
}
]
},
{
"line": "* Normal organ function including:",
"criterions": [
{
"exact_snippets": "Normal organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "normal"
}
]
}
]
},
{
"line": "* WBC >= 3,000/mm^3",
"criterions": [
{
"exact_snippets": "WBC >= 3,000/mm^3",
"criterion": "WBC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Absolute neutrophil count >= 1,500/mm^3",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count >= 1,500/mm^3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Platelet count >= 100,000/mm^3",
"criterions": [
{
"exact_snippets": "Platelet count >= 100,000/mm^3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Bilirubin normal",
"criterions": [
{
"exact_snippets": "Bilirubin normal",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": "normal"
}
]
}
]
},
{
"line": "* AST and ALT =< 2.5 times upper limit of normal",
"criterions": [
{
"exact_snippets": "AST ... =< 2.5 times upper limit of normal",
"criterion": "AST",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "times upper limit of normal"
}
}
]
},
{
"exact_snippets": "ALT =< 2.5 times upper limit of normal",
"criterion": "ALT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "times upper limit of normal"
}
}
]
}
]
},
{
"line": "* LVEF normal by echocardiogram or nuclear scan",
"criterions": [
{
"exact_snippets": "LVEF normal by echocardiogram or nuclear scan",
"criterion": "LVEF",
"requirements": [
{
"requirement_type": "normality",
"expected_value": "normal"
},
{
"requirement_type": "assessment method",
"expected_value": [
"echocardiogram",
"nuclear scan"
]
}
]
}
]
},
{
"line": "* Creatinine normal OR Creatinine clearance >= 60 mL/min",
"criterions": [
{
"exact_snippets": "Creatinine normal",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "Creatinine clearance >= 60 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "* FEV1 >= 1 L* and DLCO >= 50%* [Note: *Only if baseline CT scan of chest shows parenchymal lung disease OR there is a history of chronic obstructive or other pulmonary disease]",
"criterions": [
{
"exact_snippets": "FEV1 >= 1 L",
"criterion": "FEV1",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "L"
}
}
]
},
{
"exact_snippets": "DLCO >= 50%",
"criterion": "DLCO",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
]
},
{
"exact_snippets": "baseline CT scan of chest shows parenchymal lung disease",
"criterion": "parenchymal lung disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "history of chronic obstructive or other pulmonary disease",
"criterion": "chronic obstructive or other pulmonary disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* No prior chemotherapy, radiotherapy, or definitive therapeutic surgery (e.g., mastectomy, lumpectomy, or axillary dissection) for this cancer but prior sentinel lymph node biopsy for this malignancy allowed",
"criterions": [
{
"exact_snippets": "No prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior ... radiotherapy",
"criterion": "prior radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior ... definitive therapeutic surgery",
"criterion": "prior definitive therapeutic surgery",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "prior sentinel lymph node biopsy for this malignancy allowed",
"criterion": "prior sentinel lymph node biopsy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No prior adjuvant chemotherapy for a previous breast malignancy",
"criterions": [
{
"exact_snippets": "No prior adjuvant chemotherapy for a previous breast malignancy",
"criterion": "prior adjuvant chemotherapy for a previous breast malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterions": [
{
"exact_snippets": "No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterion": "combination antiretroviral therapy",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": false
}
]
}
]
},
{
"line": "* No other concurrent investigational agents",
"criterions": [
{
"exact_snippets": "No other concurrent investigational agents",
"criterion": "concurrent investigational agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No other concurrent anticancer agents or therapies",
"criterions": [
{
"exact_snippets": "No other concurrent anticancer agents or therapies",
"criterion": "concurrent anticancer agents or therapies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG performance status 0-1",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Fertile patients must use effective contraception",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* No other invasive malignancy within the past 5 years except curatively treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix",
"criterions": [
{
"exact_snippets": "No other invasive malignancy within the past 5 years",
"criterion": "invasive malignancy",
"requirements": [
{
"requirement_type": "time since last occurrence",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "years"
}
},
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except curatively treated basal cell or squamous cell skin cancer",
"criterion": "curatively treated basal cell or squamous cell skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "except ... carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No history of allergic reactions attributed to compounds of similar chemical or biological composition to tipifarnib or other study drugs (e.g., imidazoles or quinolones)",
"criterions": [
{
"exact_snippets": "No history of allergic reactions attributed to compounds of similar chemical or biological composition to tipifarnib or other study drugs (e.g., imidazoles or quinolones)",
"criterion": "allergic reactions to compounds similar to tipifarnib or other study drugs",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* No other uncontrolled illness including, but not limited to, any of the following: ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric illness/social situations that would preclude study compliance",
"criterions": [
{
"exact_snippets": "uncontrolled illness ... ongoing or active infection",
"criterion": "ongoing or active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled illness ... symptomatic congestive heart failure",
"criterion": "symptomatic congestive heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled illness ... unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled illness ... cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled illness ... psychiatric illness/social situations that would preclude study compliance",
"criterion": "psychiatric illness/social situations",
"requirements": [
{
"requirement_type": "impact on study compliance",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Exclusion criteria:",
"criterions": []
},
{
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}